Generating functional CD8+ T cell memory response under transient CD4+ T cell deficiency: Implications for vaccination of immunocompromised individuals

European Journal of Immunology

Volumn 38, Issue 7, 2008, Pages 1857-1866

  Smith, Corey ^a   Martinez, Michelle ^a   Cooper, Leanne ^a   Rist, Michael ^a   Zhong, Jie ^a   Khanna, Rajiv ^a  

^a Australian Centre for Vaccine Development   (Australia)

Author keywords

Cancer; Helper T cells; Memory T cells; Vaccination; Virus

Indexed keywords

ADENOVIRUS VECTOR; CANCER VACCINE; CD3 ANTIGEN; CD4 ANTIGEN; CD44HI ANTIGEN; EPITOPE; GAMMA INTERFERON; HERMES ANTIGEN; HLA A2 ANTIGEN; LATENT MEMBRANE PROTEIN 1; LATENT MEMBRANE PROTEIN 2; UNCLASSIFIED DRUG; EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV ENCODED NUCLEAR ANTIGEN 1; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; EBV-ENCODED NUCLEAR ANTIGEN 1; EPSTEIN BARR VIRUS ANTIGEN; MATRIX PROTEIN; RECOMBINANT VACCINE; VIRUS VACCINE;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CANCER IMMUNIZATION; CANCER PREVENTION; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; EXPERIMENTAL NEOPLASM; IMMUNE DEFICIENCY; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; TUMOR GROWTH; ADOPTIVE TRANSFER; ANIMAL; EPSTEIN BARR VIRUS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; METABOLISM;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; IMMUNOCOMPROMISED HOST; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MICE; MICE, TRANSGENIC; VACCINES, SYNTHETIC; VIRAL MATRIX PROTEINS; VIRAL VACCINES;

EID: 50549087381     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737933     Document Type: Article

References (34)

1. Smith, C. M., Wilson, N. S., Waithman, J., Villadangos, J. A., Carbone, F. R., Heath, W. R. and Belz, G. T., Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity. Nat. Immunol. 2004. 5: 1143-1148.
2. Sun, J. C. and Bevan, M. J., Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003. 300: 339-342.
3. + T cells after acute infection. Nat. Immunol. 2004. 5: 927-933.
4. Shedlock, D. J. and Shen, H., Requirement for CD4 Tcell help in generating functional CD8 T cell memory. Science 2003. 300: 337-339.
5. Shedlock, D. J., Whitmire, J. K., Tan, J., MacDonald, A. S., Ahmed, R. and Shen, H., Role of CD4 T cell help and costimulation in CD8 T cell responses during Listeria monocytogenes infection. J. Immunol. 2003. 170: 2053-2063.
6. Spina, M., Sandri, S. and Tirelli, U., Hodgkin's disease in HIV-infected individuals. Curr. Opin. Oncol. 1999. 11: 522-526.
7. Tirelli, U., Errante, D., Dolcetti, R., Gloghini, A., Serraino, D., Vaccher, E., Franceschi, S. et al., Hodgkin's disease and human immunodeficiency virus infection: Clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. J. Clin. Oncol. 1995. 13: 1758-1767.
8. Biggar, R. J., Jaffe, E. S., Goedert, J. J., Chaturvedi, A., Pfeiffer, R. and Engels, E. A., Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood 2006. 108: 3786-3791.
9. Tirelli, U., Serraino, D., Spina, M. and Carbone, A., Epstein-Barr virus-encoded latent membrane protein-1 expression as prognostic factor in AIDS-related non-Hodgkin's lymphoma. AIDS 1995. 9: 99-100.
10. Diehl, V. and Josting, A., Hodgkin's disease. Cancer J. 2000. 6 Suppl 2: S150-158.
11. Weiss, R., Mitrou, P., Arasteh, K., Schuermann, D., Hentrich, M., Duehrsen, U., Sudeck, H. et al., Acquired immunodeficiency syndrome-related lymphoma: Simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival-results of the German Multicenter Trial. Cancer 2006. 106: 1560-1568.
12. + T cells from patients with Hodgkin lymphoma following in vitro stimulation with recombinant polyepitope. J. Immunol. 2006. 177: 4897-4906.
13. Duraiswamy, J., Bharadwaj, M., Tellam, J., Connolly, G., Cooper, L., Moss, D., Thomson, S. et al., Induction of therapeutic T cell responses to subdominant tumor-associated viral oncogene after immunization with replication-incompetent polyepitope adenovirus vaccine. Cancer Res. 2004. 64: 1483-1489.
14. Duraiswamy, J., Sherritt, M., Thomson, S., Tellam, J., Cooper, L., Connolly, G., Bharadwaj, M. and Khanna, R., Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma. Blood 2003. 101: 3150-3156.
15. + Tcells in the control of mouse Burkitt lymphoma in vivo. J. Clin. Invest. 2004. 114: 542-550.
16. Darrah, P. A., Patel, D. T., De Luca, P. M., Lindsay, R. W., Davey, D. F., Flynn, B. J., Hoff, S. T. et al., Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 2007. 13: 843-850.
17. McKay, P. F., Schmitz, J. E., Barouch, D. H., Kuroda, M. J., Lifton, M. A., Nickerson, C. E., Gorgone, D. A. and Letvin, N. L., Vaccine protection against functional CTL abnormalities in simian human immunodeficiency virus-infected rhesus monkeys. J. Immunol. 2002. 168: 332-337.
18. Wherry, E. J. and Ahmed, R., Memory CD8 T cell differentiation during viral infection. J. Virol. 2004. 78: 5535-5545.
19. + T cell help. J. Exp. Med. 1997. 186: 65-70.
20. + T cell help. J. Immunol. 1991. 147: 4069-4073.
21. + T-helper and a T-killer cell. Nature 1998. 393: 474-478.
22. Bennett, S. R., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F. and Heath, W. R., Help for cytotoxic-T cell responses is mediated by CD40 signalling. Nature 1998. 393: 478-480.
23. + T cell help. Eur. J. Immunol. 2005. 35: 3460-3467.
24. + T cells. J. Exp. Med. 2007. 204: 2015-2021.
25. + T cell counts. PLoS Med. 2007. 4: E96.
26. + T cell memory via TRAIL-mediated activation-induced cell death. Nature 2005. 434: 88-93.
27. + T lymphocytes. Nature 2003. 421: 852-856.
28. Vitiello, A., Marchesini, D., Furze, J., Sherman, L. A. and Chesnut, R.W., Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J. Exp. Med. 1991. 173: 1007-1015.
29. Duraiswamy, J., Burrows, J. M., Bharadwaj, M., Burrows, S. R., Cooper, L., Pimtanothai, N. and Khanna, R., Ex vivo analysis of T cell responses to Epstein-Barr virus-encoded oncogene latent membrane protein 1 reveals highly conserved epitope sequences in virus isolates from diverse geographic regions. J. Virol. 2003. 77: 7401-7410.
30. Khanna, R., Burrows, S. R., Nicholls, J. and Poulsen, L. M., Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): Evidence for HLA-A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes. Eur. J. Immunol. 1998. 28: 451-458.
31. Lee, S. P., Tierney, R. J., Thomas, W. A., Brooks, J. M. and Rickinson, A. B., Conserved CTL epitopes within EBV latent membrane protein 2: A potential target for CTL-based tumor therapy. J. Immunol. 1997. 158: 3325-3334.
32. + T cell epitope in Epstein-Barr virus latent membrane protein 2. J. Virol. 2003. 77: 2757-2761.
33. Lyons, A. B. and Parish, C. R., Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 1994. 171: 131-137.
34. Khanna, R., Burrows, S. R., Kurilla, M. G., Jacob, C. A., Misko, I. S., Sculley, T. B., Kieff, E. and Moss, D. J., Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J. Exp. Med. 1992. 176: 169-176.